Ipilimumab-induced renal granulomatous arteritis: a case report

BACKGROUND: Immune Checkpoint Inhibitors (ICPIs) are promising new drugs in treatment of advanced tumours targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD1) or its ligand (PDL-1). Ipilimumab is a monoclonal antibody targeting the CTLA-4 receptor used in tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemoine, Mathilde, Dilly, Baptiste, Curie, Alexandre, Hébert, Vivien, Laurent, Charlotte, Hanoy, Mélanie, Grangé, Steven, Guerrot, Dominique, François, Arnaud, Bertrand, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788031/
https://www.ncbi.nlm.nih.gov/pubmed/31604452
http://dx.doi.org/10.1186/s12882-019-1552-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788031/
https://www.ncbi.nlm.nih.gov/pubmed/31604452
http://dx.doi.org/10.1186/s12882-019-1552-2

Ejemplares similares